02.06.2013 Views

Aanesthetic Agents for Day Surgery - NIHR Health Technology ...

Aanesthetic Agents for Day Surgery - NIHR Health Technology ...

Aanesthetic Agents for Day Surgery - NIHR Health Technology ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

90<br />

Conclusions<br />

Many adults and parents of children wish to avoid<br />

an inhalational induction. However, after receiving<br />

an inhalational induction, two-thirds of patients<br />

would be happy to receive one again.<br />

When selecting and recommending a technique<br />

<strong>for</strong> a day patient, the anaesthetist should bear the<br />

following outcomes in mind:<br />

• In both adults and children a sevoflurane/<br />

sevoflurane anaesthetic regimen is associated<br />

with a higher incidence of PONV than a<br />

regimen incorporating propofol. In children,<br />

sevoflurane/sevoflurane is also associated<br />

with agitation in recovery.<br />

• In children a sevoflurane/sevoflurane regimen<br />

is more expensive than propofol/halothane<br />

or the modelled cost of propofol/isoflurane.<br />

However, the value parents place on their child<br />

receiving an inhalational induction balances<br />

out the additional cost.<br />

• A propofol-containing regimen appears to<br />

confer anti-emetic protection. The additional<br />

anti-emetic benefit conferred by TIVA, as<br />

opposed to propofol/volatile agent, is not<br />

statistically significant. PONV aside, clinicians<br />

may also select TIVA <strong>for</strong> its ‘volatile-free’<br />

environment.<br />

Implications <strong>for</strong> future research<br />

The CESA project identified a number of<br />

areas where further research is needed. Specific<br />

anaesthetic-related issues requiring further work<br />

are discussed below. A concern more general<br />

to the remainder of healthcare that has been<br />

highlighted by this study is the role of patients’<br />

preferences in decision-making and implications<br />

<strong>for</strong> further research in this area are also<br />

explored below.<br />

Use of opioid analgesics<br />

The national practice survey indicated that<br />

analgesia is provided by intraoperative opioids in<br />

60–70% of adults, with a relatively small number<br />

receiving NSAIDs either pre- or intraoperatively.<br />

The high usage of opioids, with almost half of all<br />

patients receiving fentanyl, is perhaps surprising,<br />

given their association with nausea and vomiting.<br />

The use of NSAIDs <strong>for</strong> perioperative analgesia<br />

may, in practice, be higher than the survey<br />

suggests, <strong>for</strong> two reasons. First, the survey did<br />

not ask about the administration of postoperative<br />

analgesics, and these agents may be widely used<br />

in the postoperative period. Second, the survey<br />

instrument asked the respondent to identify just<br />

one intraoperative analgesic. Respondents may<br />

have recorded opioid usage in preference to a<br />

concurrent usage of NSAIDs.<br />

The use of these analgesics could affect the<br />

clinical effectiveness and costs of and patient<br />

preferences <strong>for</strong> different anaesthetic regimens.<br />

This is a question that was not investigated in<br />

the CESA RCT, and further work may clarify the<br />

impact of opioid use on patient outcome after<br />

day surgery. Observational studies may prove<br />

the most useful method <strong>for</strong> identification of<br />

practice patterns.<br />

Use of prophylactic anti-emetics<br />

A distinction was made between prophylactic antiemetics<br />

and those given <strong>for</strong> treatment of nausea<br />

or vomiting. Around half the respondents do<br />

not give routine anti-emetic prophylaxis to adult<br />

patients, while 30–40% always use prophylaxis,<br />

with ondansetron and cyclizine being the most<br />

popular agents. The use of prophylactic antiemetics<br />

was lower in paediatric patients. Despite<br />

the prohibition of prophylactic anti-emetics, the<br />

overall incidence of nausea and vomiting in the<br />

CESA RCT was low. This may be because the<br />

protocol precluded the use of intraoperative<br />

morphine, although small numbers of patients<br />

received other short-acting opioids. This<br />

raises questions around the necessity <strong>for</strong> the<br />

widespread use of prophylactic anti-emetics<br />

revealed in the national survey. Systematic<br />

review of the literature around the use of<br />

these agents in day surgery may help to<br />

answer these questions.<br />

Risks associated with PONV<br />

The CESA RCT <strong>for</strong> adults found that an increased<br />

risk of PONV was associated with gender, with<br />

women of childbearing age being more at risk,<br />

whether undergoing gynaecological or general<br />

surgery. Higher risk was also associated with a<br />

longer anaesthetic duration, and with agitation<br />

in the recovery area. It was not within the scope<br />

of the trial to determine whether this agitation<br />

was a cause or a consequence of feeling nauseated<br />

or vomiting. Similar results have been reported<br />

in other evaluations. However, further research<br />

is required to explore the potential causes and<br />

management implications of these events, such<br />

as the clinical and economic impact of risk<br />

assessment of patients.<br />

Other combinations of anaesthetics<br />

The CESA RCT was not able to compare all<br />

possible combinations of anaesthetic regimens<br />

and treatment protocols currently used in routine

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!